Biotech

Category / Pharmaceuticals & Biotech / Biotech

MYOS Corporation to Present at the Eighth Annual OneMedForum Conference on January 13, 2015

CEDAR KNOLLS, NJ: Presentation and Live Webcast on Tuesday, January 13, 2015, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time ...

Immunovaccine to Present at 7th Annual Biotech Showcase Conference

HALIFAX, NOVA SCOTIA: ...

Boston Therapeutics to Present at 8th Annual OneMedForum Conference in San Francisco

MANCHESTER, NH: CEO David Platt to Present on Tuesday, January 13 at 9:10 AM PT ...

Kadmon Corporation Initiates Phase 2 Clinical Trial Evaluating KD025 in Psoriasis

NEW YORK, NY: Preliminary Results Expected in First Half of 2015 ...

Omni Bio to Present at Biotech Showcase 2015

FORT COLLINS, CO: ...

Arch Biopartners Announces Private Placement

TORONTO, ONTARIO: ...

Atossa Genetics to Present at Upcoming Investor Conferences in January 2015

SEATTLE, WA: ...

Global Blood Therapeutics Completes $48 Million Series B Financing

SOUTH SAN FRANCISCO, CA: Proceeds to Support Clinical Development of GBT440 for the Treatment of Sickle Cell Disease ...

Boston Therapeutics'' sugardown(R) Shown to Reduce Glucose Levels Following Consumption of Sugary Beverages

MANCHESTER, NH: Completed Sydney University Study Finds Glycemic Index Reduced Following Consumption of Sugary Beverages Along With sugardown(R) ...

ProMetic Provides Q4 2014 Clinical Development and Commercial Milestones Update

LAVAL, QUEBEC: - IND for IVIG filed with the FDA - License/Milestone fees secured to contribute $ 9 million to Q4 2014 - Enrolment of DKD patients in PBI-4050 clinical program ongoing - no serious adverse events (&q ...

diaDexus, Inc. Updates on 2014 Achievements and 2015 Initiatives

SOUTH SAN FRANCISCO, CA: ...

SOHM Received Confirmed Orders for OTC Products

CORONA, CA: ...

AntriaBio Announces $7 Million Private Placement

LOUISVILLE, CO: ...

Abattis Maintains It Is Still the Worldwide Exclusive Licensee to Certain VDL Technology

VANCOUVER, BRITISH COLUMBIA: ...

3-V Biosciences Announces Closing of $28.5M Financing Round

MENLO PARK, CA: ...

Prima BioMed Receives NASDAQ Notice of Bid Price Deficiency

SYDNEY, AUSTRALIA: ...

Cellceutix Adds Dr. Daniel Jorgensen as Chief Medical Officer

BEVERLY, MA: ...

Miraculins Announces Shares for Debt Settlement

WINNIPEG, MANITOBA: ...

Horizon Pharma plc Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. for Filing an ANDA Against PENNSAID(R) 2%

DUBLIN, IRELAND: ...

Miraculins Completes Amendment to 2013 Scout DS(R) Asset Purchase Agreement With VeraLight